XT
ACAD icon

XTX Topco’s Acadia Pharmaceuticals ACAD Stock Holding History

XTX Topco’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,520
Closed -$593K – 2024
2024
Q2 		$593K Buy
+36,520
New +$589K 0.05% 577
2024
Q1 		– Sell
-12,961
Closed -$406K – 1776
2023
Q4 		$406K Sell
12,961
-22,962
-64% -$548K 0.09% 389
2023
Q3 		$749K Buy
+35,923
New +$976K 0.13% 194
2023
Q2 		– Sell
-31,261
Closed -$588K – 1359
2023
Q1 		$588K Buy
31,261
+6,686
+27% +$127K 0.12% 208
2022
Q4 		$391K Sell
24,575
-14,096
-36% -$220K 0.08% 419
2022
Q3 		$633K Buy
+38,671
New +$626K 0.16% 153
2021
Q3 		– Sell
-11,903
Closed -$290K – 655
2021
Q2 		$290K Buy
+11,903
New +$269K 0.1% 377

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return